211 related articles for article (PubMed ID: 7139557)
1. The role of tumor markers in the management of colorectal cancer.
Go VL; Zamcheck N
Cancer; 1982 Dec; 50(11 Suppl):2618-23. PubMed ID: 7139557
[TBL] [Abstract][Full Text] [Related]
2. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
Wanebo HJ
Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of colorectal cancer.
Simon JB
Compr Ther; 1986 Aug; 12(8):15-9. PubMed ID: 3742993
[TBL] [Abstract][Full Text] [Related]
4. CEA radioimmunoassay. Clinical applications in colorectal cancer.
Huyghe J
Acta Chir Belg; 1983; 83(2):77-88. PubMed ID: 6858539
[TBL] [Abstract][Full Text] [Related]
5. The use of carcinoembryonic antigen in the clinical management of patients with colorectal cancer.
Steele G; Zamcheck N
Cancer Detect Prev; 1985; 8(3):421-7. PubMed ID: 4064062
[TBL] [Abstract][Full Text] [Related]
6. [Standards, options and recommendations for tumor markers in colorectal cancer].
Eche N; Pichon MF; Quillien V; Gory-Delabaere G; Riedinger JM; Basuyau JP; Daver A; Buecher B; Conroy T; Dieu L; Bidart JM; Deneux L;
Bull Cancer; 2001 Dec; 88(12):1177-206. PubMed ID: 11792611
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
Yu BM
Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
[TBL] [Abstract][Full Text] [Related]
8. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
9. Immunology and immunotherapy of colorectal cancer.
Gold P
Can J Surg; 1978 May; 21(3):212-3. PubMed ID: 647509
[TBL] [Abstract][Full Text] [Related]
10. [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers].
Terabe K; Ichihashi H; Kamei H; Kondo T
Gan To Kagaku Ryoho; 1984 Jan; 11(1):111-6. PubMed ID: 6696454
[TBL] [Abstract][Full Text] [Related]
11. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
Wählby L
Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
[No Abstract] [Full Text] [Related]
12. Carcinoembryonic antigen: 3 years' experience in a cancer clinic.
Koch M; McPherson TA; Morrish DW
Can Med Assoc J; 1977 Apr; 116(7):769-71. PubMed ID: 849560
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
Koch M; Washer G; Gaedke H; McPherson TA
J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
[TBL] [Abstract][Full Text] [Related]
14. Role of carcinoembryonic antigen in the management of advanced colorectal cancer.
Mitchell EP
Semin Oncol; 1998 Oct; 25(5 Suppl 11):12-20. PubMed ID: 9786312
[TBL] [Abstract][Full Text] [Related]
15. [Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring].
Takeda A; Shimada H; Nakajima K; Imaseki H; Okazumi S; Takayama W; Hayashi H; Iwasaki K; Sasagawa S; Chou A; Natsume T; Kouno T; Kondou S; Maeda T; Hori S; Suzuki T; Ochiai T; Isono K
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2189-94. PubMed ID: 10635303
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.
Chester KA; Begent RH
Clin Exp Immunol; 1984 Dec; 58(3):685-93. PubMed ID: 6509799
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of preoperative carcinoembryonic antigen in stomach and colorectal cancer.
Staab HJ; Anderer FA; Brummendorf T; Fischer R
Cancer Detect Prev; 1983; 6(1-2):149-53. PubMed ID: 6883376
[TBL] [Abstract][Full Text] [Related]
19. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of postoperative determination of CEA in carcinoma of the large intestine].
Florianello F; Gorla C; Biraghi T; Caron R; Scortecci V
Minerva Med; 1986 Apr; 77(18):739-41. PubMed ID: 3714087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
